BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17145903)

  • 1. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
    Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I
    Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of a DTaP-IPV//PRP approximately T combination vaccine given with hepatitis B vaccine: a randomized open-label trial.
    Capeding MR; Cadorna-Carlos J; Book-Montellano M; Ortiz E
    Bull World Health Organ; 2008 Jun; 86(6):443-51. PubMed ID: 18568273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.
    Anderson PW; Pichichero ME; Stein EC; Porcelli S; Betts RF; Connuck DM; Korones D; Insel RA; Zahradnik JM; Eby R
    J Immunol; 1989 Apr; 142(7):2464-8. PubMed ID: 2784464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
    Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER
    Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
    Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
    Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age.
    Käyhty H; Peltola H; Eskola J; Rönnberg PR; Kela E; Karanko V; Mäkelä PH
    Pediatrics; 1989 Dec; 84(6):995-9. PubMed ID: 2587155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP
    Dev Biol Stand; 1986; 65():169-75. PubMed ID: 2881821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Premature infants and hepatitis B vaccination. Study Group Prevention Neonatal Hepatitis B].
    Del Canho R; Grosheide PM; Gerards LJ; Heijtink RA; Schalm SW
    Tijdschr Kindergeneeskd; 1992 Aug; 60(4):105-11. PubMed ID: 1440551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood.
    Eskola J; Käyhty H; Gordon LK; Hovi T; Stenvik M; Rönnberg PR; Kela E; Peltola H
    Pediatr Infect Dis J; 1988 Jul; 7(7):480-4. PubMed ID: 3261414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in vaccines and immunization practices.
    Casto DT
    Pharmacotherapy; 1992; 12(6 Pt 2):94S-103S. PubMed ID: 1480505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the vaccination of 3-month-old infants with Haemophilus influenzae type B (Hi b) capsular polysaccharide conjugated to tetanus protein (PRT-T) Pediatric Group of the Lyon Region].
    Langue J; Fritzell B; Preziozi MP; Houmeau P
    Pediatrie; 1991; 46(12):821-4. PubMed ID: 1667038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants.
    Madore DV; Johnson CL; Phipps DC; Popejoy LA; Eby R; Smith DH
    Pediatrics; 1990 Mar; 85(3):331-7. PubMed ID: 2304786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants.
    Lenoir AA; Granoff PD; Granoff DM
    Pediatrics; 1987 Aug; 80(2):283-7. PubMed ID: 3112729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified schedule for routine pertussis immunization.
    Swartz TA; Roumiantzeff M; Peyron L; Stopler T; Kanaaneh H; Leitner L; Goldblum N
    Dev Biol Stand; 1985; 61():289-96. PubMed ID: 2872116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Costs and benefits of vaccination against Haemophilus influenzae type b].
    Martens LL; ten Velden GH; Bol P
    Ned Tijdschr Geneeskd; 1991 Jan; 135(1):16-20. PubMed ID: 1899290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.